Northern Trust Corp Cogent Biosciences, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 719,452 shares of COGT stock, worth $7.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

719,452

Previous 715,094 0.61%

Holding current value

$7.84 Million

Previous $4.81 Million 26.2%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.01 - $9.04 $26,191 - $39,396	4,358 Added 0.61%	719,452 $6.06 Million
Q1 2024 May 14, 2024	BUY	$4.38 - $9.02 $6,600 - $13,593	1,507 Added 0.21%	715,094 $4.81 Million
Q4 2023 Feb 13, 2024	BUY	$4.06 - $10.08 $2,943 - $7,308	725 Added 0.1%	713,587 $4.2 Million
Q3 2023 Nov 13, 2023	BUY	$9.69 - $13.34 $954,775 - $1.31 Million	98,532 Added 16.04%	712,862 $6.95 Million
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.24 $624,509 - $839,442	63,402 Added 11.51%	614,330 $7.27 Million
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $82,257 - $126,991	8,193 Added 1.51%	550,928 $5.94 Million
Q4 2022 Feb 13, 2023	BUY	$10.65 - $14.84 $75,955 - $105,838	7,132 Added 1.33%	542,735 $6.27 Million
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $1.69 Million - $3.05 Million	179,678 Added 50.48%	535,603 $7.99 Million
Q2 2022 Aug 12, 2022	BUY	$3.92 - $9.73 $242,024 - $600,739	61,741 Added 20.99%	355,925 $3.21 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.7 $79,989 - $131,056	-15,064 Reduced 4.87%	294,184 $2.2 Million
Q4 2021 Feb 08, 2022	SELL	$7.51 - $10.81 $159,227 - $229,193	-21,202 Reduced 6.42%	309,248 $2.65 Million
Q3 2021 Nov 15, 2021	SELL	$5.99 - $9.14 $69,148 - $105,512	-11,544 Reduced 3.38%	330,450 $2.78 Million
Q2 2021 Aug 13, 2021	BUY	$7.82 - $9.3 $2.2 Million - $2.62 Million	281,768 Added 467.85%	341,994 $2.77 Million
Q1 2021 May 12, 2021	BUY	$7.47 - $12.34 $50,392 - $83,245	6,746 Added 12.61%	60,226 $529,000
Q4 2020 Feb 11, 2021	BUY	$9.04 - $13.01 $483,459 - $695,774	53,480 New	53,480 $601,000

Others Institutions Holding COGT

# of Institutions

159

Shares Held

114M

Call Options Held

104K

Put Options Held

163K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $717M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cogent Biosciences, Inc. Transaction History